TARDBP and synucleinopathy: Although in vivo research and validation are needed to establish the diagnostic value of retinal proteinopathy, results from this study hold promise for the development of non-invasive and accessible methods for the (early) detection and monitoring of AD, synucleinopathies and TDP-43-related disorders.